{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Clostridium difficile Infection and Fecal Bacteriotherapy

Activity Steps

Purpose of Activity

To present a case study and discussion of the treatment and management options of Clostridium difficile (C. diff) infection using recently updated clinical guidelines for patient management.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define Clostridium difficile (C. diff) infection and its implications related to pseudomembranous colitis (PMC) and antibiotic-associated diarrhea (AAD).
  2. List and explain current medication recommendations for treatment of C. diff infections.
  3. Outline the use, risks, and benefits of fecal bacteriotherapy in the treatment of C. diff infections.
Price: $24.95

Credits:

  • ANCC 2.5 CH
  • DC - BON 2.5 CH
  • KY-BON 2.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Test Code: GN0113
Published: January/February 2013
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Authors: Indya Mitchell RN, MSN, FNP-BC, KaSheena Shropshire RN, MSN, FNP-C, Jennifer Ruel DNP, RN, FNP-BC
Categories: Gastrointestinal , Infection
Specialties: Infection Control